Showing all 5 results
-
-
Camosunate Children (1-6years)
₦1,500Based on your requested format, here is the evidence-based profile for Camosunate Children (1-6 years).
Camosunate Children (1-6 years)
-
Short Description Camosunate Children is a fixed-dose Artemisinin-based Combination Therapy (ACT) antimalarial formulated specifically for younger children (ages 1 to 6). It contains a combination of Artesunate (50mg) and Amodiaquine (150mg). It is primarily used for the treatment of acute, uncomplicated malaria. Because children in this age group are more vulnerable to severe malaria, this specific dose ensures effective parasite clearance while maintaining a safe pediatric profile.
-
-
camosunate peduatric (below 1yr)
₦1,500-
Camosunate Pediatric is an Artemisinin-based Combination Therapy (ACT). It contains two antimalarial agents: Artesunate and Amodiaquine. It is primarily used for the treatment of uncomplicated malaria caused by Plasmodium falciparum in infants and small children.
-
-
Visita plus 30g
₦1,000Visita Plus 30g is a topical eye lubricant gel designed to relieve dryness and irritation of the eyes. Widely used in Nigeria, it helps moisturize the eyes, reduce discomfort, protect the eye surface, and provide long-lasting relief from dryness and irritation when used as recommended by a healthcare professional.
End of content
End of content





